Skip to Content
Merck
CN
All Photos(2)

Key Documents

Safety Information

855777C

Avanti

20:0 Lyso PC

Avanti Research - A Croda Brand

Synonym(s):

1-eicosanoyl-sn-glycero-3-phosphocholine; PC(20:0/0:0)

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C28H58NO7P
CAS Number:
Molecular Weight:
551.74
UNSPSC Code:
51191904
NACRES:
NA.25

description

1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform

Assay

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

form

liquid

packaging

pkg of 1 × 2.5 mL (855777C-25mg)

manufacturer/tradename

Avanti Research - A Croda Brand

concentration

10 mg/mL (855777C-25mg)

shipped in

dry ice

storage temp.

−20°C

General description

Lysophosphatidylcholine (Lyso-PC) is a component of blood plasma, vascular tissue and lipoproteins.

Application

20:0 Lyso PC has been used as an internal standard in liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify very long chain fatty acids (VLCFA) levels in peroxisome biogenesis disorders (PBD) cell lines.

Biochem/physiol Actions

Lysophosphatidylcholine (Lyso-PC) is associated with inflammatory diseases and atherosclerosis. It stimulates the expression of genes for growth factors and cellular adhesion molecules.

Packaging

5 mL Clear Glass Sealed Ampule (855777C-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Pictograms

Skull and crossbonesHealth hazard

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

Target Organs

Central nervous system, Liver,Kidney

Storage Class Code

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK

WGK 3

Flash Point(F)

does not flash

Flash Point(C)

does not flash

Regulatory Information

易制毒化学品(2类)
危险化学品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Development and validation of a UHPLC-ESI-MS/MS method for the simultaneous quantification of mammal lysophosphatidylcholines and lysophosphatidylethanolamines in serum
Suarez-Garcia S, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 1055, 86-97 (2017)
The peroxisomal AAA ATPase complex prevents pexophagy and development of peroxisome biogenesis disorders
Law KB, et al.
Autophagy, 13(5), 868-884 (2017)
Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells
Wong JT, et al.
Test, 273(12), 6830-6836 (1998)
Kelsey B Law et al.
Autophagy, 13(5), 868-884 (2017-05-20)
Peroxisome biogenesis disorders (PBDs) are metabolic disorders caused by the loss of peroxisomes. The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service